GMA-304

N/A

Report date: 2025/01/03 14:50:12

Base Information

Drug NameGMA-304
Drug Alias NameGMA-304
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEndothelin receptor antagonistsNatriuretic peptide receptor 1 agonists
TargetsEndothelin receptorNatriuretic peptide receptor 1
Therapy Area/IndicationsAcutely decompensated congestive heart failurePulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGmax Biopharm Llc
China Registration ClassN/A

Develop Information

Active CompaniesGmax Biopharm Llc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsAcutely decompensated congestive heart failure

Other Information

ATC CodeN/A
Related LinksN/A